Notable News Review: Juno Therapeutics Inc (NASDAQ:JUNO), Plains GP Holdings LP (NYSE:PAGP)

On Friday, Shares of Juno Therapeutics Inc (NASDAQ:JUNO), added 5.11% and closed at $31.68 in the last trading session. The last trading range of the stock ranges between $30.35 and $32.00. Juno Therapeutics, Inc. (JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, recently stated financial results and business highlights for the third quarter 2016.

“JCAR017, a key product candidate of our CD19 platform, has shown encouraging preliminary efficacy and safety results in NHL and pediatric ALL. At the forthcoming American Society of Hematology meeting, additional data from our Phase I trial for JCAR017 in NHL patients will be presented,” said Hans Bishop, Juno’s President and Chief Executive Officer. “Progress with CAR T therapy continues as we strive to bring these innovative product candidates to patients battling cancer. We look forward to the forthcoming presentations at ASH, counting 11 total presentations from a number of ongoing and accomplished studies.”

Plains GP Holdings LP (NYSE:PAGP), dropped -0.25% and closed at $12.11 in the last trading session. The last trading range of the stock ranges between $11.87 and $12.18. The company’s Market capitalization is $7.76 Billion with the total Outstanding Shares of 268.35 million. Plains All American Pipeline, L.P. (NYSE: PAA) and Plains GP Holdings (NYSE: PAGP) recently stated third-quarter 2016 results. “PAA stated third-quarter adjusted EBITDA of $450 million, which included solid performance in our fee-based Facilities segment and in-line performance from our fee-based Transportation segment, offset by Supply and Logistics segment performance that was below the low-end of our third quarter guidance. Our third quarter Supply and Logistics segment was influenced by a combination of delayed EBITDA recognition associated with our NGL inventory costing and the timing of crude oil sales, in addition to lower than forecasted EBITDA as a result of continued margin compression and less favorable market conditions for both our crude oil and NGL activities,” said Greg Armstrong, Chairman and CEO of Plains All American.

“Looking forward, we are encouraged by recent signals that indicate the current industry cycle has reached a bottom and are supportive of PAA’s positive intermediate-to-long term view. However, we continue to anticipate a challenging midstream environment over the near term and we have incorporated those expectations into our forward guidance.”

Leave a Reply

Your email address will not be published. Required fields are marked *